Tabradol
Product Images NDC 70332-106

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tabradol (NDC 70332-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by California Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tabradol Cyclobenzaprine Label (Tabradol Api Label Cs22 A1 (label Cyclo Hci .28g Repack) California Pharma Llc)

Label for Cyclobenzaprine Hydrochloride from California Pharmaceuticals, LLC, showing active ingredient chemical name, CAS number 6202-23-9, net contents of 0.28 g, and a warning not to use if the safety seal is broken. The label states Rx Only and includes the repackager's address in Camarillo, CA.*

FDA Label Image

Tabradol Flavor Label (Tabradol Cherry Flavoring Cs26 A1 Label Tabradol Flavoring California Pharma Llc)

Label for Tabradol Cherry Oral Suspension Vehicle from California Pharmaceuticals LLC. The label notes the product is free of sugar, dye, and parabens and lists ingredients such as purified water, glycerin, sorbitol, and cherry flavor. The net content is 250 ml (8.5 fl oz). Manufacturer information for California Pharmaceuticals LLC, Camarillo, CA is included.*

FDA Label Image

Tabradol (pharmacist instructions page 1)

Instructions for preparation of Tabradol (cyclobenzaprine hydrochloride) RapidPaq cherry oral suspension kit. The document includes kit contents for preparing 250 mL of 1.13 mg/mL cyclobenzaprine hydrochloride suspension, safety inspection, and compounding guidelines for pharmacists.*

FDA Label Image

Tabradol Pharmacist Instructions Page 2 (Tabradol Pamphlet Cs34 A1 Insert Tabradol Kit California Pharma Llc Page 2)

Pharmacist preparation instructions for Tabradol, a cyclobenzaprine hydrochloride 1.13 mg/mL cherry oral suspension kit from California Pharmaceuticals, LLC. The text outlines steps for transferring the oral suspension vehicle, combining the cyclobenzaprine hydrochloride with cherry flavoring, and labeling the final suspension.*

FDA Label Image

Tabradol Principal Label (Tabradol Principal Display Cs125 A1 Label Tabradol Kit California Pharma Llc)

Label for Tabradol (cyclobenzaprine hydrochloride 1.13 mg/mL), a cherry-flavored oral suspension kit labeled as a muscle relaxant. The kit contains 250 mL total, split into two 125 mL bottles with flavor and suspension vehicles, an oral dispenser, and instructions. It is repacked and distributed by California Pharmaceuticals, LLC, and includes a barcode and safety seal information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.